Minimising the risks of allergen-specific injection immunotherapy.

Minimising the risks of allergen-specific injection immunotherapy.

Item
http://www.wikidata.org/entity/Q34070329
The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergistsGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoImmediate-type allergy to drugs and related compounds: evaluation and management.Undertreatment of allergy: exploring the utility of sublingual immunotherapy.A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.A battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy.Looking ahead at the potential benefits of biotechnology-derived allergen therapeuticsEAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Off-label use of omalizumab in non-asthma conditions: new opportunities.
P2860

Minimising the risks of allergen-specific injection immunotherapy.

Item
http://www.wikidata.org/entity/Q34070329
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Minimising the risks of allergen-specific injection immunotherapy.
@ast
Minimising the risks of allergen-specific injection immunotherapy.
@en
Minimising the risks of allergen-specific injection immunotherapy.
@nl
type
label
Minimising the risks of allergen-specific injection immunotherapy.
@ast
Minimising the risks of allergen-specific injection immunotherapy.
@en
Minimising the risks of allergen-specific injection immunotherapy.
@nl
prefLabel
Minimising the risks of allergen-specific injection immunotherapy.
@ast
Minimising the risks of allergen-specific injection immunotherapy.
@en
Minimising the risks of allergen-specific injection immunotherapy.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Minimising the risks of allergen-specific injection immunotherapy.
@en
P2093
P2888
P304
P31
P356
10.2165/00002018-200023040-00005
P433
P478
P577
P6179
P698
P921